Avandia and Paxil settlements
Only a week after Glaxo SmithKline (GSK) agreed to pay $460 million to settle over 10,000 personal injury lawsuits related to Avandia, it was reported that GSK has agreed to pay $1 billion dollars to settle 800 cases related to birth defects caused by the GSK anti-depressant Paxil, taken by pregnant women. Both of these settlements are part of the $2.4 billion GSK has set aside to resolve pending litigation, according to corporate filings last week.
This is what happens when there is lax regulation.
Related posts:
